2023³â Á¦6Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2023-06-03
±³À°ÀÏÀÚ : 2023-06-03
±³À°Àå¼Ò : ¼¿ï ½ºÀ§½º±×·£µåÈ£ÅÚ
±³À°ÁÖÁ¦ : 2023³â Á¦6Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѳ»°úÇÐȸ
´ã´çÀÚ : ´ëÇѳ»°úÇÐȸ
¿¬¶ôó : 02-793-4364
À̸ÞÀÏ : kaim4364@kaim.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 31 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í »çÀüµî·Ï: (³»°úÀü°øÀÇ¡¤Àü¹®ÀÇ) 40,000¿ø / (Ÿ°ú/ºñȸ¿ø) 60,000¿ø / ´çÀϵî·Ï: (³»°úÀü°øÀÇ¡¤Àü¹®ÀÇ) 50,000¿ø / (Ÿ°ú/ºñȸ¿ø) 70,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 08:30~08:55 Recent Update on the Management of Chronic Viral Hepatitis °¹Î±Ô(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 08:55~09:20 Recent Update on the Management of Hepatocellular Carcinoma ÀÌÇѾÆ(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 09:20~09:45 Diagnosis and Treatment of Asymptomatic Gallbladder Disease ÀÌ°æÁÖ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 09:45~10:10 Approach of Asymptomatic CA 19-9 Elevation ¹ÚÅ¿µ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 10:30~11:00 Diagnosis and Treatment of Colon Subepithelial Lesion ±è¼ºÁß(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 11:00~11:30 Recent Update on the Post-Polypectomy Surveillance À±¼ø¸¸(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 11:30~12:00 Diagnosis and Management of GERD ¹ÚÂùÇõ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 12:00~12:30 Diagnosis and Management of H. pylori Infection ÀÌ»óÇ¥(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 08:30~09:00 What Are the Key Changes and Implication for Clinical Practice in COPD (GOLD guideline 2023)? ÀÌâ·ü(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 09:00~09:30 IPF and Progressive Pulmonary Fibrosis (PPF) ¼ÛÁø¿ì(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 09:30~10:00 Recent Treatment Strategy for MDR-Tb ½Éż±(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 10:30~11:00 Pathophysiology of Cough and Updated Treatment of Chronic Refractory Cough ¾ÈÅÂÁØ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 11:00~11:30 Biologics in Airway Diseases ¹ÚÇýÀ±(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 11:30~12:30 Targeted Treatment of NSCLC ¿©Ã¢µ¿(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 08:30~09:00 Transplantation Immunology Overview ±è¸í±Ô(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 09:00~09:30 Pre-Transplant Evaluation of Donor and Recipient ±èÈ¿Áø(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 09:30~10:00 Basics in Immunosuppressant for KT ¿ÀÅ·Å(Àü³²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 10:30~11:00 Desensitization in ABO and HLA–incompatible KT Á¶ÀåÈñ(°æºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 11:00~11:30 Evaluation and Management of Antibody-Mediated Rejection ÀÌÁ¤Ç¥(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 11:30~12:00 Prevention and Management of Infectious Complication in KT recipients ÇÔ¿µ·Ï(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 12:00~12:30 Management of Pre and Post-Transplant Malignancy in KT recipients ±èÅÂÈñ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 08:30~09:00 Respiratory Infection in Immunocompromised Host: RSV, Parainfluenza, Metapneumovirus Infection È«È¿¸²(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 09:00~09:30 Gastrointestinal Infection: Non-Typhoidal Salmonella, Campylobacter and Other Gastrointestinal Infection À̽¼ø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 09:30~10:00 Mosquito-Borne Diseases, Malaria, Dengue, Chikungunya, & Zika Virus ÀÓÀçÇü(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 10:30~11:10 Korean Guidelines for Use of Antibiotics for Intra-abdominal Infections in Adults ±èÁöÀº(ÇѾçÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 11:10~11:50 Strategies to Prevent Ventilator-Associated Pneumonia, Ventilator-Associated Events, and Nonventilator Hospital-Acquired Pneumonia in Acute-Care Hospitals: 2022 Update Çã°æ¹Î(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 11:50~12:30 SHEA Statement on Stewardship during Public Health Emergencies, Antibiotic Stewardship lecture for junior staff ±è¿ëÂù(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 13:30~14:00 Current Guidelines for Acute Coronary Syndrome À±ÇõÁØ(°è¸íÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 14:00~14:30 Current Guidelines for Atrial Fibrillation ¹ÚÁ¾¼º(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 14:30~15:00 Current Guidelines for Heart Failure À±Á¾Âù(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 15:30~16:00 Update on Management of Dyslipidemia ¿À±Ôö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 16:00~16:30 Update on Valvular Heart Disease ȲÈñÁ¤(°æÈñÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 16:30~17:00 Update on Bradyarrhythmia °íÁ¡¼®(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦2ȸÀÇÀå 17:00~17:30 Update on Artificial Intelligence in Cardiovascular Field À±´ö¿ë(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦5ȸÀÇÀå 13:30~14:00 Diagnosis of Critical Illness–induced Corticosteroid Insufficiency ±èÈ¿Á¤(À»ÁöÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦5ȸÀÇÀå 14:00~14:30 Primary Aldosteronism 2023 Update À̽ÂÈÆ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦5ȸÀÇÀå 14:30~15:00 Update on the Diagnosis and Management of PCOS ÀÌÇýÁø(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦5ȸÀÇÀå 15:30~16:00 Bird¡¯s Eye View on Lipid and Human Health - Beyond Atherosclerosis ¹Ú¿µ¹Ì(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦5ȸÀÇÀå 16:00~16:30 Final Destination: Targeting LDL Cholesterol Á¤Ã¢Èñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦5ȸÀÇÀå 16:30~17:00 What¡¯s New in Obesity Treatment ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦5ȸÀÇÀå 17:00~17:30 Contemporary Guideline for Fatty Liver Disease ÀÌ¿ëÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 13:30~14:00 Recent Advances in TMA (TTP) ÀÓÈ£¿µ(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 14:00~14:30 Recent Advances in MDS È«ÁؽÄ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 14:30~15:00 Recent Advances in CML ±è°æÇÏ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 15:30~16:00 Modification of Anticancer Drug in Patients with Renal Impairment ±èÀÎÈ£(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 16:00~16:30 Modification of Anticancer Drug in Patients with Hepatic Impairment ¿À¼Ò¿¬(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 16:30~17:00 Anticancer Treatment in Patients with Autoimmune/Pulmonary Disease ±ÇÁ¤Çý(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦1ȸÀÇÀå 17:00~17:30 Anticancer Treatment in Elderly Patients with Cancer ±èÁöÇö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 13:30~14:15 New Biologic Therapies for Difficult-to-Treat Allergy Diseases ¾ç¹Î¼®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 14:15~15:00 Current and Emerging Biologic and Small Molecule Therapies for Atopic Dermatitis ±è¹Ì¾Ö(Â÷ÀÇ°úÇдëÇÐ)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 15:30~16:10 Recent Update on the Diagnosis and Management of Angioedema ±è¼öÁ¤(°æºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 16:10~16:50 A Hands-on Approach to Allergic Contact Dermatitis and Patch Testing ±è¼ºÁø(Àü³²ÀÇ´ë ÇǺΰú)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦3ȸÀÇÀå 16:50~17:30 Diagnosis and Management of Insect Allergy ½ÅÀ¯¼·(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 13:30~14:00 Update of Axial Spondyloarthritis ¹Ú¹ÎÂù(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 14:00~14:30 Treatment of Systemic Sclerosis and Pulmonary Arterial Hypertension ±è±âÁ¶(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 14:30~15:00 Update of Gout and CPPD ÃÖÀ±Á¤(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 15:30~16:00 A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still¡¯s Disease with Tocilizumab ÃÖ¼¼¸²(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 16:00~16:30 Idiopathic Inflammatory Arthritis in the Auditory Canal in a Patient with Hearing Impairment ¾È¼ö¹Î(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 16:30~17:00 Overlap Syndrome of Systemic Sclerosis and Cryoglobulinemic Vasculitis with Central Nervous System Involvement Á¤À¯Áø(¼¿ïÀÇ·á¿ø)
±³À°½Ã°£ 06¿ù 03ÀÏ Á¦4ȸÀÇÀå 17:00~17:30 Tumor-like Presentation of Cerebral Vasculitis in a Patient with Systemic Lupus Erythematosus: A Biopsy-confirmed Case °Á¾¿Ï(´ë±¸ÆÄƼ¸¶º´¿ø)